AAPS Conference on Advances in Pharmaceutical Processing
June 19-20, 2003
Hilton Parsippany, Parsippany, NJ

The abstract submission deadline of April 22, 2003 has expired. We are no longer accepting abstract submissions for this meeting. PROGRAM UPDATE: Friday, June 21 - PAT Track – 2-5 pm Light-Induced Fluorescence in Development and Manufacture of Pharmaceutical Dosage Forms C.K. Lai, Ph.D. Massachusetts Institute of Technology Near IR in Development and Manufacture of Pharmaceutical Dosage Forms Joseph G. Stowell, Ph.D. Purdue University Applications of In Situ Raman Technology for Pharmaceutical Process Development Simon Leung, Ph.D. Bristol-Myers Squibb Company     Srinivas Tummala, Ph.D. Bristol-Myers Squibb Company Goals and Objectives This conference focuses on areas of interest to those in pharmaceutical development. Mid-level and junior scientists and graduate students are encourgaged to attend and network with academic, industrial and regulatory scientists present. Conference Objectives Gain knowledge on a broad range of pharmaceutical technologies Provide a forum for pharmaceutical scientists of all levels and students to learn about and exchange ideas on pharmaceutical processing Conference Topics Industrial, academic and regulatory perspectives on Process Analytical Technologies Applications of Process Analytical Technologies Presentations by academic and industrial scientists on issues of solids modifications Updates on excipient functionality and harmonization Presentations on artificial intelligence and expert systems in formulation studies Presentations by academic and industrial scientists on processing of proteins and microencapsulation Planning Committee Robin H. Bogner, Ph.D., University of Connecticut, Chair Colleen E. Ruegger, Ph.D., Novartis Pharmaceuticals, Vice Chair Hoshang M. Unvala, Ph.D., Bayer Corporation, Contributed Papers Chair Chuck A. Bass, The Dow Chemical Co., Exhibits Chair